FOLD — AMICUS THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.39% (2020 Q2)
Avg. % of fund
0.15%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 537,433 -816,065 -60.3% 0.07% $4.2M $7.88
2025 Q2 ADDED 1,353,498 +533,472 +65.1% 0.16% $7.8M $5.73
2025 Q1 ADDED 820,026 +394,943 +92.9% 0.17% $6.7M $8.16
2024 Q4 ADDED 425,083 +165,923 +64.0% 0.09% $4.0M $9.42
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75%
← Back to ALGERT GLOBAL LLC Holdings